Once-Weekly Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2–4 and 10

  1. Capehorn, M.
  2. Ghani, Y.
  3. Hindsberger, C.
  4. Johansen, P.
  5. Jódar, E.
Journal:
Diabetes Therapy

ISSN: 1869-6961,  1869-6953

Year of publication: 2020

Volume: 11

Issue: 5

Pages: 1061-1075

Type: Article

DOI: 10.1007/S13300-020-00796-Z GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus